摘要
目的:探讨β2-微球蛋白水平的测定对肺心病患者肾功能变化的临床意义。方法:检测56例肺心病患者血、尿β2-微球蛋白水平,并与正常组对照。结果:肺心病患者急性加重期血、尿β2-微球蛋白水平明显高于缓解期与正常对照组(P<0.001),肺心病缓解期患者与正常对照组的血、尿β2-微球蛋白水平无显著差异(P>0.05)。结论:血、尿β2-微球蛋白水平的检测有助于发现肺心病患者早期的肾功能异常。
ve: To explore the clinical significance of determination levels of serum and urine β2-microglobulin in patients with pulmonary heart disease (PHD). Methods:Levels of serum and urine β2-microglobulin in 56 patients with PHD were detected and analyzed. Results: Compared with control group and PHD patients in remission stage, the levels of serum and urine β2-microglobulin of PHD patients in acute stage increased significantly(P<0. 001) ;the levels of serum and urine β2-microglobulin between control group and PHD patients in remission stage were no significant (P>0. 05). Conclusion: Determination levels of serum and urine β2-microglobulin contribute to discover early abnormal change of kidney function.
出处
《心血管康复医学杂志》
CAS
2002年第3期222-223,共2页
Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词
Β2-微球蛋白
肺心病
肾功能
β2-microglobulin
Pulmonary heart disease
Kidney function
